Header
HOME COMPANY TECHNOLOGY PRODUCTS RESEARCH AREAS TECHNICAL RESOURCES

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


meet with us

 

 

trachea

 

-Cell Culture startup gets $500K investment, looks to artificial organs


click to see: Press Release on medcitynews.com

 

 

Cell-grower Nanofiber Solutions lands $500,000 TechColumbus investment


click to see: Press Release on bizjournals.com

 

 

-Man Travels To Sweden For

Life-Saving Trachea Operation


click to see: Press Release on wbaltv.com

 

 

-Cell culture company sees promise in making scaffolds for artificial organs

 

click to see: Press Release on medcitynews.com

 

 

-Baltimore cancer patient gets second chance at life Read

 

click to see: Press Release on abc2news.com

 

 

-Cancer Patient Receives a

Man-Made Windpipe


click to see: Press Release on healthland.time.com

 

 

-Synthetic Windpipe Is Used to Replace Cancerous One

 

click to see: Press Release on nytimes.com

 

 

-Organ printing may be huge

plastics market

 

click to see: Press Release on plasticstoday.com

 

 

 

 

 

 

*Click on COMPANY tab for more news and press releases*

 

 

 

 

 

Nanofiber Solutions manufactures revolutionary 3D nanofiber technologies* for cell culture, cancer research and stem cell expansion.

 

Nanofiber Solutions uses a technology platform that provides researchers with more biologically realistic cell culture leading to:

 

 
  • more effective biomedical research
  • earlier breakthroughs
  • faster and cheaper time to market for drug development
  • improved stem cell expansion rates.

Our technology uses aligned and randomly oriented polymer nanofibers integrated into standard multi-well cell culture dishes and can be easily scaled up for larger bioreactor systems.

 

 

 

Our products:

 

 
  • facilitate high-throughput tests involving cell migration/invasion, drug discovery, stem cell expansion and directed differentiation, and in vitro diagnostics
  • provide a 3-D topography that mimics the in vivo topography
  • are optically transparent to allow for live-cell imaging and real time quantification of cell mobility
  • have the same general size and shape of standard cell culture dishes allowing ease of acceptance and compatibility with automated systems and current equipment.
 

 

 

How Our Products Compare

 

  Nanofiber Solutions v. traditional plates:  
 

Historically, cell culture for life science research has been performed on flat, tissue culture polystyrene (TCPS) because it is cheap, optically clear, and many cells grow well on it. In reality, however, living organisms are made up of an extracellular matrix that presents both aligned physical structure and mechanical support to the cells. TCPS lacks this aligned three-dimensional (3-D) component and cells behave very differently on this flat, smooth substrate than they do in true biological settings.

Not surprisingly, drugs developed using TCPS as an in vitro substrate experience a >99% failure rate in later testing. 

 

 


  NFS v. other 3D cell culture products:  
 

Nanofiber Solutions scaffolds are engineered to mimic cellular-scale structures.  Our standard plates include polycaprolactone (PCL) nanofibers averaging less than a micron in diameter.  The fiber dimensions and specific physical properties are optimized to produce ideal synthetic in vitro models.  No other 3D cell culture product matches our ability to physically mimic the in vivo environment and create a realistic scaffold for all types of adherent cells.

We also offer specialized plates using other polymers and fiber diameters tailored for specific cell types and extracellular matrix conditions (to mimic normal, pathological, and aged ECM environments).

 



  NFS v. basement membrane matrices (gels):  
 

Compared with gels, Nanofiber Solutions synthetic scaffolds have the following benefits – they:

  • do not require specialized transportation or storage
  • supply a physical structure for cell adherence and growth
  • allow for easy cell extraction for gene and protein analyses
  • are sold in standard cell culture plate sizes and thus are adaptable for automation
  • do not introduce a third-party animal contaminant in stem cell use.
 

 

 

  *Patents-pending